Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Pulmonary Hypertension

  Free Subscription


Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 17 articles:
HTML format
Text format



Single Articles


    February 2018
  1. ABID S, Kebe K, Houssaini A, Tomberli F, et al
    New NO Donor NCX 1443: Therapeutic Effects on Pulmonary Hypertension in the SAD Mouse Model of Sickle Cell Disease.
    J Cardiovasc Pharmacol. 2018 Feb 8. doi: 10.1097/FJC.0000000000000570.
    PubMed     Text format     Abstract available


    October 2016
  2. CAMPOS C, Luz de Castro A, Vicente Tavares AM, Fernandes RO, et al
    Effect of free and nanoencapsulated copaiba oil on monocrotaline-induced pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  3. FARES WH
    Pushing the Envelope on the Indications and Doses of Pulmonary Arterial Hypertension Medications: What's Reasonable?
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format    


    January 2016
  4. PARIKH KS, Rajagopal S, Fortin T, Tapson VF, et al
    Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  5. LI Y, Geng X, Wang H, Cheng G, et al
    CTRP9 ameliorates pulmonary-arterial hypertension through attenuating inflammation and improving endothelial cell survival and function.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  6. AKAGI S, Nakamura K, Matsubara H, Kondo M, et al
    Intratracheal administration of prostacyclin analog-incorporated nanoparticles ameliorates the development of monocrotaline and sugen/hypoxia-induced pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  7. SHANG P, He ZY, Chen JF, Huang SY, et al
    Absence of the Adenosine A2A Receptor Confers Pulmonary Arterial Hypertension Through RhoA/ROCK Signaling Pathway in Mice.
    J Cardiovasc Pharmacol. 2015;66:569-75.
    PubMed     Text format     Abstract available


    November 2015
  8. ZHENG Y, Ma H, Hu E, Huang Z, et al
    Inhibition of FGFR Signaling With PD173074 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Rescues BMPR-II Expression.
    J Cardiovasc Pharmacol. 2015;66:504-14.
    PubMed     Text format     Abstract available


    October 2015
  9. FANG X, Chen X, Zhong G, Chen Q, et al
    Mitofusin 2 downregulation triggers pulmonary artery smooth muscle cell proliferation and apoptosis imbalance in rats with hypoxic pulmonary hypertension via the PI3K/Akt and mitochondrial apoptosis pathways.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


  10. LI MX, Jiang DQ, Wang Y, Chen QZ, et al
    Signal mechanisms of vascular remodeling in the development of pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  11. IGLARZ M, Landskroner K, Bauer Y, Vercauteren M, et al
    Comparison of macitentan and bosentan on right ventricular remodeling in a rat model of non-vasoreactive pulmonary hypertension.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    June 2015
  12. WANG K, Ma J, Pang Y, Lao J, et al
    Niflumic acid attenuated pulmonary artery tone and vascular structural remodeling of pulmonary arterial hypertension induced by high pulmonary blood flow in vivo.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    April 2015
  13. DAMY T, Hobkirk J, Walters M, Ciobanu A, et al
    Development of a Human Model for the Study of Effects of Hypoxia, Exercise and Sildenafil on Cardiac and Vascular Function in Chronic Heart Failure.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    February 2015
  14. NAKATA TM, Tanaka R, Yoshiyuki R, Fukayama T, et al
    Effects of single drug and combined short-term administration of sildenafil, pimobendan, and nicorandil on right ventricular function in rats with monocrotaline-induced pulmonary hypertension.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    January 2015
  15. DING M, Lei J, Qu Y, Zhang H, et al
    Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    July 2014
  16. KUNITA-TAKANEZAWA M, Abe K, Hirooka Y, Kuwabara Y, et al
    Novel Dual Endothelin Receptor Antagonist Macitentan Reverses Severe Pulmonary Arterial Hypertension in Rats.
    J Cardiovasc Pharmacol. 2014.
    PubMed     Text format     Abstract available


    January 2014
  17. LIU C, Fang C, Cao G, Liu K, et al
    Ethyl pyruvate ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.
    J Cardiovasc Pharmacol. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: